RPLP1P13

Across TCGA pan-cancer cohorts, RPLP1P13 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of RPLP1P13’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where RPLP1P13 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPLP1P13 is over-expressed in tumor, although a few such as BRCA and THCA show the opposite, repressed pattern.

HNSC, COAD, and KIRP are the cancer types where RPLP1P13 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPLP1P13 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	Male	All	+0.211	.003	6	view →
COAD	All	All	+0.220	<.001	4	view →
KIRP	All	III,IV	+0.210	.002	4	view →
LIHC	All	II,III,IV	+0.089	.006	4	view →
KIRC	Male	All	+0.089	.012	4	view →
CHOL	All	All	+0.267	.021	3	view →
BRCA	All	III,IV	−0.244	.003	2	view →
READ	All	All	+0.231	.046	1	view →
THCA	Female	All	−0.092	.029	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

RPLP1P13–HNSC

Open the HNSC breakdown →